Results · Apr-Jun 2026
Morepen Laboratories Q1 FY27 results
BlockbusterBlockbuster: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales grew 34% to ₹570 crore from ₹425 crore in Apr-Jun 2025.
Operating profit grew 241% to ₹82.5 crore, an operating margin of 14.5% (up 8.8 points from a year ago).
Net profit grew 425% to ₹56.4 crore from ₹10.7 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +18%, net profit +258%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 570.1 | 425.2 | +34% |
| Operating profit (EBITDA) | 82.5 | 24.2 | +241% |
| Operating margin | 14.5% | 5.7% | +8.8 pts |
| Net profit | 56.4 | 10.7 | +425% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.